WRF
Waddell & Reed Financial’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $131M | Sell |
1,071,487
-142,615
| -12% | -$17.4M | 0.27% | 108 |
|
|
2020
Q4 | $186M | Sell |
1,214,102
-98,381
| -7% | -$15.1M | 0.39% | 62 |
|
|
2020
Q3 | $110M | Buy |
1,312,483
+285,151
| +28% | +$23.9M | 0.26% | 104 |
|
|
2020
Q2 | $75.5M | Buy |
1,027,332
+7
| +0% | +$514 | 0.2% | 136 |
|
|
2020
Q1 | $43.6M | Buy |
1,027,325
+5
| +0% | +$212 | 0.14% | 171 |
|
|
2019
Q4 | $62.6M | Sell |
1,027,320
-19,008
| -2% | -$1.16M | 0.16% | 172 |
|
|
2019
Q3 | $42.9M | Buy |
1,046,328
+44,410
| +4% | +$1.82M | 0.11% | 211 |
|
|
2019
Q2 | $47.2M | Hold |
1,001,918
| – | – | 0.12% | 214 |
|
|
2019
Q1 | $35.8M | Buy |
1,001,918
+1,918
| +0.2% | +$68.5K | 0.09% | 266 |
|
|
2018
Q4 | $28.6M | Hold |
1,000,000
| – | – | 0.08% | 277 |
|
|
2018
Q3 | $44.4M | Buy |
+1,000,000
| New | +$44.4M | 0.1% | 239 |
|